Pulmonary capillary blood volume (V0) was determined in 30 young women, 14 of whom were taking oral contraceptives. Duplicate estimates of V, in the 16 women not taking contraceptives showed a significant increase in the second half of the menstrual cycle. Formulae for prediction of V. in women were derived for the first and second halves of the cycle. V, was shown to be of the same order in women taking contraceptives containing oestrogen and progestogen as in those in the premenstrual phase of the cycle. Possible causes of these findings and their relevance to the diagnosis of pulmonary thromboembolic disease are discussed.
Oral contraceptives appear to have many different actions on the vascular system. On the one hand, they may cause vasodilatation (Goodrich and Wood, 1964) and an increase in blood volume (Walters and Lim, 1969) while, on the other, they may contribute to intravascular coagulation (Dugdale and Masi, 1969; Inman, Vessey, Westerholm, and Engelund, 1970) and endarteritis (Irey, Manion, and Taylor, 1970) . In the investigation of obliterative disease of the pulmonary vascular bed it has been suggested that estimation of the pulmonary capillary blood volume (Va) may be a helpful diagnostic tool (Nadel et al., 1966) . The present study was planned to determine the normal values for V. in females, and to find if oral contraceptive therapy alters these values.
METHODS
Thirty women, aged between 18 and 35 years, were studied. All were non-smokers or smoked fewer than five cigarettes per day. Fourteen of the subjects were taking oral contraceptives (oestrogen plus progestogen) at the time of study. The other 16 were studied at two separate times in the menstrual cyclebetween 7 and 10 days after and again betweeii 2 and 4 days before the onset of menstruation. In addition, nine normal men were each studied on two occasions in order to determine the relative error of the techniques. The physical characteristics of the subjects and details of contraceptive therapy are given in Tables I and II. The techniques used were based on those of McNeill, Rankin, and Forster (1958) Ogilvie, Forster, Blakemore, and Morton (1957) except that neon rather than helium was used in the gas mixture. For the low oxygen measurements, a gas containing 0.40 carbon monoxide, 0.4% neon, and 21 % oxygen in nitrogen was used. For the high oxygen measurements 0.4% carbon monoxide and 0.4°h neon in oxygen was used.
The subjects were studied in the sitting position, smokers not being tested until at least three hours after their last cigarette. Two single breath manoeuvres were carried out using the low oxygen gas. High oxygen gas was then substituted and the subjects carried out two further single breath manoeuvres. Finally, two more measurements of DL were made using the high oxygen gas after the subjects had breathed 100% oxygen for one to two minutes. In From the duplicate measurements in the male controls, the relative error of repeated determinations was found to be 5-6% for DL, 7-3% for Ve, and 11 % for Dm (Table V) . The results were also found to be repeatable for three women in whom duplicate measurements were made at the same phase of the menstrual cycle (Table VI) .
The relationships between DL, VC, Dm and height, surface area and total lung capacity were tested in the controls at both stages of the cycle. The values of r are given in Table VII . The best predictor of DL, VC, and Dm at either stage is total lung capacity (at S.T.P.D.). Prediction formule Dm=11-61 TLC+221 (r=083).
DISCUSSION
Estimation of pulmonary capillary blood volume has been suggested as a method for investigation of occlusive disease of the small pulmonary arteries and may be of particular value in subjects with multiple small emboli leading to pulmonary hypertension (Nadel et al., 1966) . However, the value of such a test must depend on a knowledge of the results obtained in normal subjects.
Although a number of authors have recorded normal values for V. and Dm in their laboratories (McNeill et al., 1958; Lewis, Lin, Noe, Komisaruk, 1958; Ross, Maddock, and Ley, 1961; Daly, Ross, and Behnke, 1963; McCredie, Lovejoy, and Yu, 1964; and Krumholz, 1966) An increase in plasma volume in the luteal phase of the menstrual cycle has been suspected on the basis of the fall in haematocrit and gain in weight that may be found at this time (Danforth, Boyer, and Graff, 1946) . At the same time in the cycle, venous tone is decreased (McCausland, Holmes, and Trotter, 1963) , this effect also occurring during pregnancy and in subjects on oestrogen-progestogen contraceptives (Goodrich and Wood, 1964) . Recently, it has been demonstrated that subjects show an increase in weight, plasma volume, and cardiac output when they start taking these contraceptives (Walters and Lim, 1969) . Vascular changes during the menstrual cycle have been demonstrated directly in the conjunctival vessels, using slit-lamp microscopy (Landesman, Douglas, Dreishpoon, and Holze, 1953) . At this site vascular dilatation occurs in the luteal phase of the cycle, followed by increased vasomotion and then vascular spasm immediately premenstrually. Logan (1967) noticed that pulmonary capillary blood volume in five normal females was greater in the second than in the first half of the cycle, though the difference was not statistically significant. The present study shows that there is a significant variation in V,, though not in DL or D., through the menstrual cycle. In all subjects studied save one, an increase in Vc occurred the week before menstruation and this suggests that either progesterone or its combination with oestrogen is responsible. Confirmation of this comes from the finding that V. in subjects on oestrogen-progestogen tablets is also raised compared to controls studied in the first half of the cycle.
The increase in V. is not likely to be related to an increase in plasma volume, as determination of V. depends on the amount of haemoglobin rather than plasma in the pulmonary capillaries. In general, there is a slight drop in haematocrit premenstrually (Danforth et al., 1946) which, if it affected the estimation of V. at all, would cause an artefactually low result. A more likely explanation of the changes observed is that progesterone, either alone or with oestrogen, causes distension of the pulmonary capillary bed, possibly secondary to an action on the arterioles or venules similar to that observed at other sites (Landesman et al., 1953; McCausland et al., 1963; and Goodrich and Wood, 1964) . It is not easy to understand why these hormones should have a dual action on respiration, acting both as a respiratory stimulant (Goodland, Reynolds, McCoord,andPommerenke, 1953; Doring, Loeschcke, and Ochwadt, 1950) and as a pulmonary vasodilator. Whether this second effect may contribute to the hypocapnia of pregnancy and of the luteal phase by reducing the physiological dead space is a matter for speculation. From a practical point of view, if a state of pulmonary vasodilatation exists in subjects on oral contraceptives, arteriovenous shunts may become opened and cause zones of apparent underperfusion on lung scans which might be attributed to vascular occlusion. In such circumstances determination of V. should be helpful. If V, is found to be higher than the predicted normal for females in the first half of the cycle, significant occlusion of the pulmonary vascular bed is unlikely to be present. On the other hand, a value for Vc lower than this predicted normal should arouse a strong suspicion of multiple pulmonary emboli.
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